-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the popularization of the Internet and the accelerated gathering of the external environment and policy environment, online pharmacies have ushered in a golden period
of rapid development.
of rapid development.
According to data from Minai.
com, the terminal drug sales of China's online pharmacies in the first half of 2022 have exceeded 23 billion yuan, and it is expected to exceed the 40 billion yuan mark for the whole year; 2 anti-ED drugs advanced to the top 20 chemical drugs, and 10 domestic brands such as Kelun, Baiyunshan, and Qilu were on the list; 10 exclusive varieties ranked among the top 20 proprietary Chinese medicines, and the new crown "miracle medicine" was favored.
.
.
At the same time as the rapid expansion of online pharmacies, the state has also gradually introduced relevant new regulations on control, adding two categories of drugs prohibited from sale on the Internet such as preparations of medical institutions and traditional Chinese medicine formula granules, and excluding hypoglycemic
injections.
com, the terminal drug sales of China's online pharmacies in the first half of 2022 have exceeded 23 billion yuan, and it is expected to exceed the 40 billion yuan mark for the whole year; 2 anti-ED drugs advanced to the top 20 chemical drugs, and 10 domestic brands such as Kelun, Baiyunshan, and Qilu were on the list; 10 exclusive varieties ranked among the top 20 proprietary Chinese medicines, and the new crown "miracle medicine" was favored.
.
.
At the same time as the rapid expansion of online pharmacies, the state has also gradually introduced relevant new regulations on control, adding two categories of drugs prohibited from sale on the Internet such as preparations of medical institutions and traditional Chinese medicine formula granules, and excluding hypoglycemic
injections.
01.
New regulations have been added to the control of online sales of drugs, which is conducive to hypoglycemic injections
New regulations have been added to the control of online sales of drugs, which is conducive to hypoglycemic injections
In order to further improve the relevant policies on the supervision of online sales of drugs and clarify the scope of online sales, the General Department of the State Food and Drug Administration recently organized the drafting of the "List of Prohibitions on Online Sales of Drugs (Draft for Comments)" (hereinafter referred to as the "Draft for Comments"
).
).
Source: State Food and Drug Administration
The Draft for Comments states that policies and regulations explicitly prohibit the sale of nine types of drugs, including vaccines, blood products, narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, pharmaceutical precursor chemicals, preparations of medical institutions, and granules
formulated with traditional Chinese medicine.
formulated with traditional Chinese medicine.
The other four major categories of drugs prohibited from online retail include injections (except hypoglycemic drugs), anabolics and peptide hormones (except insulin) listed in the Stimulant List, as well as varieties with high drug risk such as digoxin, disopyramide and quinidine
.
.
From the list of drug online prohibitions, two new categories have been added: medical institution preparations and traditional Chinese medicine formula granules
.
Medical institution preparations refer to those fixed prescription preparations
that have not yet been officially approved for relevant products, are not available in the market, and are only prepared and used by some medical institutions with approval according to this clinical need.
In-hospital preparations such as "myopia miracle medicine" atropine, skin cream, vitamin E milk, throat cleansing agent, trauma cream and other in-hospital preparations will be restricted by online sales, showing the regulator's careful consideration and regulatory attitude
towards drug safety.
.
Medical institution preparations refer to those fixed prescription preparations
that have not yet been officially approved for relevant products, are not available in the market, and are only prepared and used by some medical institutions with approval according to this clinical need.
In-hospital preparations such as "myopia miracle medicine" atropine, skin cream, vitamin E milk, throat cleansing agent, trauma cream and other in-hospital preparations will be restricted by online sales, showing the regulator's careful consideration and regulatory attitude
towards drug safety.
Chinese medicine formula granules are granules made of single flavor Chinese medicine pieces extracted by water, separated, concentrated, dried and granulated, under the guidance of Chinese medicine theory, according to the clinical prescription of Chinese medicine, for patients to take and use
.
.
In February 2021, the State Food and Drug Administration and other four ministries and commissions jointly issued the "Announcement on Ending the Pilot Work of Traditional Chinese Medicine Formula Granules", which pointed out that Chinese medicine formula granules must not be sold outside medical institutions, and also made it clear that the end of the pilot does not mean that the supervision of traditional Chinese medicine formula granules will be relaxed, and the drug regulatory authorities will strengthen territorial supervision
in accordance with the "four strictest" requirements.
It can be seen that it is not surprising
that traditional Chinese medicine formula granules appear in the drug network ban list.
in accordance with the "four strictest" requirements.
It can be seen that it is not surprising
that traditional Chinese medicine formula granules appear in the drug network ban list.
Source: State Food and Drug Administration
There are strict management and advantages, and the draft for comments also gives a "green channel"
for online sales of hypoglycemic injections.
Does this mean that products such as insulin and its analogues, GLP-1 receptor agonists and other products will usher in a wave of market volume in online pharmacy terminals?
for online sales of hypoglycemic injections.
Does this mean that products such as insulin and its analogues, GLP-1 receptor agonists and other products will usher in a wave of market volume in online pharmacy terminals?
According to data from Minai.
com, in recent years, the terminal sales of insulin and its analogues and GLP-1 receptor agonists in China's online pharmacies have increased significantly, approaching 100 million yuan and 40 million yuan in the first half of 2022, an increase of 966% and 2411% respectively compared with the same period, and the product sales prospects are promising
.
com, in recent years, the terminal sales of insulin and its analogues and GLP-1 receptor agonists in China's online pharmacies have increased significantly, approaching 100 million yuan and 40 million yuan in the first half of 2022, an increase of 966% and 2411% respectively compared with the same period, and the product sales prospects are promising
.
Sales trend of terminal insulin and its analogues and GLP-1 receptor agonists in Chinese online pharmacies in recent years (: million yuan)
02.
The market size may exceed 40 billion yuan! The regulation of online drug sales is gradually becoming standardized
The market size may exceed 40 billion yuan! The regulation of online drug sales is gradually becoming standardized
Regarding the standardized rectification of online retail drugs, the state has also laid out a layout
before.
Policies on online retail of pharmaceuticals in recent years
before.
Policies on online retail of pharmaceuticals in recent years
Source: State Food and Drug Administration, State Council, etc.
, compiled by Minai.
com
, compiled by Minai.
com
With the promulgation of the Measures for the Administration of Internet Drug Information Services in 2004, the concept of pharmaceutical e-commerce was officially proposed, and the online sales channels of drugs were also opened up and continuously developed
.
.
In recent years, with the gradual maturity of business models and the continuous improvement of the strategic position of "Internet +" under the influence of the epidemic, online drug sales can be said to have entered a golden period
of development.
of development.
According to data from Minai.
com, in recent years, the sales scale of terminal drugs (chemical drugs, proprietary Chinese medicines, and drug combinations) in China's online pharmacies has increased year by year, expanding from more than 10 billion yuan in 2019 to more than 30 billion yuan in 2021, and has exceeded 23 billion yuan in the first half of 2022, with a double-digit year-on-year growth and full market potential
.
com, in recent years, the sales scale of terminal drugs (chemical drugs, proprietary Chinese medicines, and drug combinations) in China's online pharmacies has increased year by year, expanding from more than 10 billion yuan in 2019 to more than 30 billion yuan in 2021, and has exceeded 23 billion yuan in the first half of 2022, with a double-digit year-on-year growth and full market potential
.
Sales of terminal drugs (chemical drugs + proprietary Chinese medicines + drug combinations) in China's online pharmacies in recent years (: 100 million yuan)
The proportion of prescription drugs has increased year by year, from 54.
6% in 2019 to 65.
4% in 2021, and has become the "main force" of online pharmacy sales, which may be related to
the gradual liberalization of the policy of online sales of prescription drugs.
6% in 2019 to 65.
4% in 2021, and has become the "main force" of online pharmacy sales, which may be related to
the gradual liberalization of the policy of online sales of prescription drugs.
The proportion of non-prescription drugs in sales rebounded in the first half of 2022, mainly due to the impact of national policy support for proprietary Chinese medicines, which greatly stimulated the demand
for OTC market for proprietary Chinese medicines.
for OTC market for proprietary Chinese medicines.
Distribution of over-the-counter/prescription drugs/double-cross varieties in China's online pharmacies in recent years (chemical drugs + proprietary Chinese medicines)
03.
Domestic chemical drug brands dominate the screen, and 10 exclusive proprietary Chinese medicines are on the list
Domestic chemical drug brands dominate the screen, and 10 exclusive proprietary Chinese medicines are on the list
From the ranking of terminal chemical products of China's online pharmacies in the first half of 2022, the sales of TOP17 products exceeded 100 million yuan, with a total sales scale of nearly 4.
5 billion yuan, and two anti-ED "miracle drugs" of sildenafil citrate tablets and tadalafil tablets continued to rank at the forefront of the list; The antifungal skin disease treatment drug bifonazole solution, vitamin AD drops commonly used in children, and minoxidil tincture, a star product specializing in the treatment of male devastation, all advanced to the top 20 products with a sales growth rate of more than 200
% in the same period.
5 billion yuan, and two anti-ED "miracle drugs" of sildenafil citrate tablets and tadalafil tablets continued to rank at the forefront of the list; The antifungal skin disease treatment drug bifonazole solution, vitamin AD drops commonly used in children, and minoxidil tincture, a star product specializing in the treatment of male devastation, all advanced to the top 20 products with a sales growth rate of more than 200
% in the same period.
In the first half of 2022, China's online pharmacy drug terminal chemical drug TOP20 products
From the perspective of brand ranking, the sales of TOP18 brands exceeded 100 million yuan, of which 10 were domestic brands, and Zhejiang Wansheng Pharmaceutical's minoxidil tincture won the crown with a market share of 2.
56%, up 5 places from last year; The sales growth rate of bifonazole solution of Jiangsu Zhiyuan Pharmaceutical and dapoxetine hydrochloride tablets of Sichuan Kelun Pharmaceutical both exceeded 300% compared with the same period, and both belong to the new brands
.
56%, up 5 places from last year; The sales growth rate of bifonazole solution of Jiangsu Zhiyuan Pharmaceutical and dapoxetine hydrochloride tablets of Sichuan Kelun Pharmaceutical both exceeded 300% compared with the same period, and both belong to the new brands
.
In the first half of 2022, China's online pharmacy drug terminal chemical drug TOP20 brand
The total sales scale of the top 20 proprietary Chinese medicine products exceeded 1.
7 billion yuan, of which the sales of Pian Zixi in the first half of 2022 exceeded 300 million yuan, ranking far ahead of the second ejiao (about 160 million yuan).
In addition to Pian Zixi, there are also 9 exclusive products on the list, including Kidney Tablets, Yi'an Ning Pills, Shu Jian Waist Pills, Compound Ejiao Pulp and so on
.
7 billion yuan, of which the sales of Pian Zixi in the first half of 2022 exceeded 300 million yuan, ranking far ahead of the second ejiao (about 160 million yuan).
In addition to Pian Zixi, there are also 9 exclusive products on the list, including Kidney Tablets, Yi'an Ning Pills, Shu Jian Waist Pills, Compound Ejiao Pulp and so on
.
In the first half of 2022, China's online pharmacy drug terminal top 20 proprietary Chinese medicine products
Note: Exclusive varieties are indicated by *
Since the beginning of this year, the new crown epidemic has been repeated, and the demand for related preventive and therapeutic drugs has surged, and Lianhua Qingwen capsules have entered the top 20
products for the first time with a sales growth rate of 45.
89%.
The sales growth rate of products such as Activating Oil and Zuogui Pill has exceeded 600% compared with the same period, and the product potential is worth looking forward to
.
products for the first time with a sales growth rate of 45.
89%.
The sales growth rate of products such as Activating Oil and Zuogui Pill has exceeded 600% compared with the same period, and the product potential is worth looking forward to
.
